Modulation of MUC1 and blood group antigen expression in gastric adenocarcinoma cells by cytokines

Cytokine

Volumn 23, Issue 3, 2003, Pages 86-93

  Grohmann, Georg P M ^a   Schirmacher, Peter ^a   Manzke, Oliver ^a   Hanisch, Franz Georg ^a   Dienes, Hans P ^a   Baldus, Stephan E ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adhesion molecules; Cytokines; Gastric cancer; Lewis blood group antigens; Mucins

Indexed keywords

BLOOD GROUP ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; MUCIN 1; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD GROUP LEWIS SYSTEM; CANCER CELL CULTURE; CANCER GROWTH; CELL STIMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA;

EID: 0042167253     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(03)00202-3     Document Type: Article

References (44)

1. Engelmann K., Baldus S.E., Hanisch F.G. Identification and topology of variant sequences within individual repeat domains of the human epithelial tumor mucin MUC1. J Biol Chem. 276:2001;27764-27769.
2. Baldus S.E., Hanisch F.G. Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia. Adv Cancer Res. 79:2000;201-248.
3. Baldus S.E., Zirbes T.K., Engel S., Hanisch F.G., Mönig S.P., Lorenzen J., et al. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int J Cancer. 79:1998;133-138.
4. Sakamoto H., Yonezawa S., Utsunomiya T., Tanaka S., Kim Y.S., Sato E. Mucin antigen expression in gastric carcinomas of young and old adults. Hum Pathol. 28:1997;1056-1065.
5. Nakamori S., Furukawa H., Hiratsuka M., Iwanaga T., Imaoka S., Ishikawa O., et al. Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer. J Clin Oncol. 15:1997;816-825.
6. Baldus S.E., Zirbes T.K., Mönig S.P., Engel S., Monaca E., Rafiqpoor K., et al. Histopathological subtypes and prognosis of gastric cancer are correlated with the expression of mucin-associated sialylated antigens: sialosyl-Lewis(a), sialosyl-Lewis(x) and sialosyl-Tn. Tumour Biol. 19:1998;445-453.
7. McDermott K.M., Crocker P.R., Harris A., Burdick M.D., Hinoda Y., Hayashi T., et al. Overexpression of MUC1 reconfigures the binding properties of tumor cells. Int J Cancer. 94:2001;783-791.
8. Nakagawa K., Akagi J., Takai E., Tamori Y., Okino T., Kako H., et al. Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma. Int J Oncol. 14:1999;425-435.
9. Satoh S., Hinoda Y., Hayashi T., Burdick M.D., Imai K., Hollingsworth M. Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule. Int J Cancer. 88:2000;507-518.
10. Schwartz B., Bresalier R.S., Kim Y.S. The role of mucin in colon-cancer metastasis. Int J Cancer. 52:1992;60-65.
11. Suwa T., Hinoda Y., Makiguchi Y., Takahashi T., Itoh F., Adachi M., et al. Increased invasiveness of MUC1 and cDNA-transfected human gastric cancer MKN74 cells. Int J Cancer. 76:1998;377-382.
12. Takada A., Ohmori K., Yoneda T., Tsuyuoka K., Hasegawa A., Kiso M., et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 53:1993;354-361.
13. Bresalier R.S., Niv Y., Byrd J.C., Duh Q.Y., Toribara N.W., Rockwell R.W., et al. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest. 87:1991;1037-1045.
14. Hayashi T., Takahashi T., Motoya S., Ishida T., Itoh F., Adachi M., et al. MUC1 mucin core protein binds to the domain 1 of ICAM-1. Digestion. 63:2001;87-92.
15. Slomiany B.L., Piotrowski J., Slomiany A. Involvement of endothelin-1 in up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun. 258:1999;17-20.
16. Moss S.F., Legon S., Davies J., Calam J. Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut. 35:1994;1567-1570.
17. Byrd J.C., Yunker C.K., Xu Q.S., Sternberg L.R., Bresalier R.S. Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology. 118:2000;1072-1079.
18. Kuninaka S., Yano T., Yokoyama H., Fukuyama Y., Terazaki Y., Uehara T., et al. Direct influences of pro-inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) on the proliferation and cell-surface antigen expression of cancer cells. Cytokine. 12:2000;8-11.
19. Smirnova M.G., Birchall J.P., Pearson J.P. TNF-alpha in the regulation of MUC5AC secretion: some aspects of cytokine-induced mucin hypersecretion on the in vitro model. Cytokine. 12:2000;1732-1736.
20. Kabir S., Daar G.A. Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma. Cancer Lett. 95:1995;207-212.
21. Wu C.W., Chi C.W., Hsieh M.C., Chao M.F., Lui W.Y., P'eng F.K. Serum tumor necrosis factor in patients with gastric cancer. Anticancer Res. 18:1998;1597-1599.
22. Dobrilla G., Benvenuti S., Amplatz S., Zancanella L. Chronic gastritis, intestinal metaplasia, dysplasia and Helicobacter pylori in gastric cancer: putting the pieces together. Ital J Gastroenterol. 26:1994;449-458.
23. Ernst P. Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol Ther. 1:1999;13-18.
24. Cornberg M., Enss M.L., Makkink M.K., Beil W., Bock C.T., Sobek-Klocke I., et al. Variation of human mucin gene expression in gastric cancer cell lines and gastric mucous cell primary cultures. Eur J Cell Biol. 78:1999;832-841.
25. Enss M.L., Cornberg M., Wagner S., Gebert A., Henrichs M., Eisenblatter R., et al. Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm Res. 49:2000;162-169.
26. Lagow E.L., Carson D.D. Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon-gamma and tumor necrosis factor-alpha. J Cell Biochem. 86:2002;759-772.
27. Clark S., McGuckin M.A., Hurst T., Ward B.G. Effect of interferon-gamma and TNF-alpha on MUC1 mucin expression in ovarian carcinoma cell lines. Dis Markers. 12:1994;43-50.
28. Majuri M.L., Pinola M., Niemela R., Tiisala S., Natunen J., Renkonen O., et al. Alpha 2,3-sialyl and alpha 1,3-fucosyltransferase-dependent synthesis of sialyl Lewis x, an essential oligosaccharide present on L-selectin counterreceptors, in cultured endothelial cells. Eur J Immunol. 24:1994;3205-3210.
29. Majuri M.L., Niemela R., Tiisala S., Renkonen O., Renkonen R. Expression and function of alpha 2,3-sialyl- and alpha 1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: role in synthesis of E-selectin counter-receptors. Int J Cancer. 63:1995;551-559.
30. Delmotte P., Degroote S., Lafitte J.J., Lamblin G., Perini J.M., Roussel P. Tumor necrosis factor alpha increases the expression of glycosyltransferases and sulfotransferases responsible for the biosynthesis of sialylated and/or sulfated Lewis x epitopes in the human bronchial mucosa. J Biol Chem. 277:2002;424-431.
31. Shimada S., Ogawa M., Schlom J., Greiner J.W. Comparison of the interferon-gamma-mediated regulation of tumor-associated antigens expressed by human gastric carcinoma cells. In Vivo. 7:1993;1-8.
32. Abril E., Real L.M., Serrano A., Jimenez P., Garcia A., Canton J., et al. Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line. Cancer Immunol Immunother. 47:1998;113-120.
33. Liu S.I., Lui W.Y., Mok K.T., Wu C.W., Chi C.W. Effect of hepatocyte growth factor on cell cycle and c-met expression in human gastric cancer cells. Anticancer Res. 17:1997;3575-3580.
34. Lehmann F.S., Terracciano L., Carena I., Baeriswyl C., Drewe J., Tornillo L., et al. In situ correlation of cytokine secretion and apoptosis in Helicobacter pylori-associated gastritis. Am J Physiol Gastrointest Liver Physiol. 283:2002;G481-G488.
35. Xia H.H., Talley N.J. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol. 96:2001;16-26.
36. Graham D.Y. Helicobacter pylori infection is the primary cause of gastric cancer. J Gastroenterol. 35:2000;90-97.
37. Kirikoshi H., Sekihara H., Katoh M. Up-regulation of WNT10A by tumor necrosis factor alpha and Helicobacter pylori in gastric cancer. Int J Oncol. 19:2001;533-536.
38. Yang J.M., Byrd J.C., Siddiki B.B., Chung Y.S., Okuno M., Sowa M., et al. Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology. 4:1994;873-884.
39. Lees C.J., Apostolopoulos V., Acres B., Ramshaw I., Ramsay A., Ong C.S., et al. Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice. Vaccine. 19:2000;158-162.
40. Graham R.A., Burchell J.M., Beverley P., Taylor-Papadimitriou J. Intramuscular immunisation with MUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneic mouse tumour cells. Int J Cancer. 65:1996;664-670.
41. Barratt-Boyes S.M., Vlad A., Finn O.J. Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses. Clin Cancer Res. 5:1999;1918-1924.
42. Akagi J., Nakagawa K., Egami H., Ogawa M. Induction of HLA-unrestricted and HLA-class-II-restricted cytotoxic T lymphocytes against MUC-1 from patients with colorectal carcinomas using recombinant MUC-1 vaccinia virus. Cancer Immunol Immunother. 47:1998;21-31.
43. Baldus S.E., Hanisch F.G., Kotlarek G.M., Zirbes T.K., Thiele J., Isenberg J., et al. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms. Cancer. 82:1998;1019-1027.
44. Kern M.A., Bamborschke S., Nekic M., Schubert D., Rydin C., Lindholm D., et al. Concentrations of hepatocyte growth factor in cerebrospinal fluid under normal and different pathological conditions. Cytokine. 14:2001;170-176.